enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Glipizide - Wikipedia

    en.wikipedia.org/wiki/Glipizide

    Glipizide, sold under the brand name Glucotrol among others, is an anti-diabetic medication of the sulfonylurea class used to treat type 2 diabetes. [1] [2] It is used together with a diabetic diet and exercise. [1] [2] It is not indicated for use by itself in type 1 diabetes. [1] [2] It is taken by mouth.

  3. Thiazolidinedione - Wikipedia

    en.wikipedia.org/wiki/Thiazolidinedione

    Thiazolidinedione ligand dependent transactivation is responsible for the majority of anti-diabetic effects. The activated PPAR/RXR heterodimer binds to peroxisome proliferator hormone response elements upstream of target genes in complex with a number of coactivators such as nuclear receptor coactivator 1 and CREB binding protein, this causes upregulation of genes (for a full list see PPARγ):

  4. SGLT2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/SGLT2_inhibitor

    [50] [44] In contrast with other anti-hyperglycemic diabetes medications , SGLT2 inhibitors enhance, rather than suppress, gluconeogenesis and ketogenesis . [ 51 ] Because SGLT2 inhibitors activate sirtuin 1 (and thus PGC-1α and FGF21 ), they are more cardioprotective than the other medications used to treat diabetes .

  5. Review links 3 potentially-blinding eye conditions to GLP-1 ...

    www.aol.com/review-links-3-potentially-blinding...

    A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — experienced vision issues, including three potentially blinding eye ...

  6. Gemigliptin - Wikipedia

    en.wikipedia.org/wiki/Gemigliptin

    After 24 weeks, the reduction from baseline for HbA1c was 0.81% for gemigliptin 25 mg twice a day (bid) and 0.77% for gemigliptin 50 mg qd, and the differences in the least square mean changes from baseline between groups (each group of gemigliptin-sitagliptin group) were −0.011% in gemigliptin 25 mg bid and 0.004% in gemigliptin 50 mg qd.

  7. Empagliflozin - Wikipedia

    en.wikipedia.org/wiki/Empagliflozin

    In the United States, empagliflozin is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure; [12] to reduce the risk of sustained decline in eGFR, end-stage kidney disease, cardiovascular death, and hospitalization in adults with chronic kidney disease at risk of progression; [12] to reduce the risk of cardiovascular death in ...

  8. Beyond Bingo: The 50+ Best Activities for Seniors in ... - AOL

    www.aol.com/lifestyle/beyond-bingo-50-best...

    People have the same basic needs at any age: to explore, have fun, learn, and live life to the fullest. The best activities for assisted living residents do much more than just pass the time ...

  9. FDA approves new type of non-opioid pain medication, 1st of ...

    www.aol.com/news/fda-approves-type-non-opioid...

    The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx ...